Betamethasone valerate patch - IBSA

Drug Profile

Betamethasone valerate patch - IBSA

Alternative Names: Betasil Plaster; Beteflam Patch; Betesil Patch

Latest Information Update: 27 Feb 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator IBSA
  • Developer Cipher Pharmaceuticals; IBSA
  • Class Anti-inflammatories; Antiallergics; Antiasthmatics; Antipsoriatics; Fluorinated steroids; Glucocorticoids; Small molecules
  • Mechanism of Action Glucocorticoid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Plaque psoriasis; Skin disorders
  • Phase III Musculoskeletal disorders
  • Phase II Psoriasis

Most Recent Events

  • 27 Feb 2018 IBSA discontinued a phase II trial for Psoriasis (finger and nail) in Italy (Topical), before February 2018 (EudraCT2014-000291-25)
  • 05 Apr 2016 Launched for Plaque psoriasis in Canada (Topical)
  • 05 Apr 2016 Pooled efficacy and adverse events data from two phase III trials in Plaque psoriasis released by IBSA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top